Daiichi Sankyo

Daiichi invests 1 bln eur near Munich to make precision cancer drugs
Reuters
Fri, 02/16/24 - 11:51 am
Daiichi Sankyo
precision medicine
cancer
Germany
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Daiichi Sankyo
AstraZeneca
Enhertu
earnings
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters
Mon, 01/22/24 - 11:15 am
BioNTech
Duality Biologics
clinical trials
breast cancer
AstraZeneca
Daiichi Sankyo
HER2+ breast cancer
Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News
Pharmaphorum
Wed, 01/17/24 - 09:38 am
Seagen
Daiichi Sankyo
patents
legal
Enhertu
USPTO
FDA grants priority review for Daiichi Sankyo-Merck’s lung cancer therapy
Pharmaceutical Business Review
Wed, 12/27/23 - 11:00 pm
Daiichi Sankyo
Merkc
patritumab deruxtecan
FDA
non-small cell lung cancer
Daiichi Sankyo unit claims $182m in Novartis patent dispute
Pharmaphorum
Wed, 12/6/23 - 10:31 am
Daiichi Sankyo
Novartis
Plexxikon
legal
patents
Tafinlar
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Reuters
Thu, 11/16/23 - 10:22 pm
Japan
Daiichi Sankyo
COVID-19
vaccines
Daiichi-Sankyo ups revenue forecast thanks to massive Merck deal
Fierce Biotech
Tue, 10/31/23 - 09:30 pm
Daiichi Sankyo
Merck
antibody-drug conjugate
‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal
Fierce Biotech
Sun, 10/29/23 - 08:56 pm
AbbVie
Daiichi Sankyo
Merck
antibody-drug conjugate
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
ESMO
Daiichi Sankyo
AstraZeneca
Enhertu
patient deaths
clinical trials
non-small cell lung cancer
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Merck
Daiichi Sankyo
AstraZeneca
antibody-drug conjugate
Seagen wins future royalties in Enhertu patent dispute
Pharmaphorum
Wed, 10/18/23 - 10:07 am
Seagen
Daiichi Sankyo
breast cancer
Enhertu
drug royalties
BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC
Fierce Biotech
Thu, 10/12/23 - 10:07 am
BioNTech
Daiichi Sankyo
antibody-drug conjugate
breast cancer
Daiichi Sankyo reports positive results from trial of breast cancer therapy
Clinical Trials Arena
Mon, 09/25/23 - 11:47 am
Daiichi Sankyo
clinical trials
Dato-DXd
breast cancer
AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead
BioSpace
Fri, 09/22/23 - 11:51 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
AstraZeneca, Daiichi Sankyo show off ADC portfolio with safety top of mind
Fierce Biotech
Tue, 09/12/23 - 12:00 pm
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
non-small cell lung cancer
Dato-DXd
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Daiichi Sankyo to close Japanese research and development subsidiary
Pharmaceutical Business Review
Tue, 08/8/23 - 10:17 am
Daiichi Sankyo
Japan
R&D
RD Novare
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Mon, 08/7/23 - 10:14 am
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche

Pages